| 释义 |
promyelocytic 英prə'miːləsaɪtɪk美prə'miːləsaɪtɪk BNC²³⁶²¹³⁺¹
基本例句
早幼粒细胞¹⁰⁰
Human promyelocytic leukemia cells HL-60 are the standard target cell line for apoptosis research, concerning which many biochemical reactions have been recognized and established.
观察依托咪酯对 HL-60细胞的作用，既可以反映依托咪酯对免疫细胞的直接作用，又有利于研究其具体的凋亡机制。 fabiao
Objective:To investigate the clinical study of Relapsed Acute Promyelocytic Leukemia APLtreated with Compound Huangdai tablets.
目的探讨复方黄黛片治疗复发急性早幼粒细胞白血病 APL的临床疗效。 dictall
Patients with certain subtypes of AML, such as acute promyelocytic leukemia APL have a higher chance of cure.
急性髓细胞性白血病 AML的分型也影响其治愈率，如急性早幼粒细胞白血病 APL的治愈率相对较高。 yeeyan
The utilization of retinoic acid as an agent of induction differentiation in clinical treatment for leukemia, particularly in acute promyelocytic leukemia, obtained significant result.
维甲酸作为一种诱导分化剂应用于临床，在血液系恶性肿瘤尤其是急性早幼粒细胞性白血病的防治中取得了显著的疗效。 cnki
Tretinoin, the first successful differentiating agent, approved by FDA for use in acute promyelocytic leukemia.
FDA批准首个有效的促分化药物-维A酸治疗急性早幼粒细胞白血病。 fimmu
Acute promyelocytic leukemiaAPL is a special subtype of acute nonlymphocytic leukemia. It advances rapidly and is often combined with severe bleeding.
急性早幼粒细胞白血病是急性非淋巴细胞白血病的一种特殊亚型，病情严重，常伴致死性出血。 chemyq
All-trans retinoic acid ATRA has been successfully used in differentiation induction therapy for acute promyelocytic leukemiaAPL, which was pioneered in China.
全反式维甲酸是由我国首创的诱导分化治疗急性早幼粒细胞白血病获得成功的药物。 cnki
As drugs have improved, use of the metal has declined, though it is still used for a rare form called acute promyelocytic leukaemia.
随着药物的不断改进，也越来越少地使用它。只是在治疗很少见的急性早幼粒细胞性白血病上还使用它。 yeeyan
Methods: The clinical manifestations, treatment and prognosis of9 acute promyelocytic leukemiaAPL patients with RAS were retrospectively studied.
方法：回顾分析9例出现 RAS的急性早幼粒细胞白血病的患者的临床表现、治疗与预后。 cnki
Objective To Summarize and compare the effects of the different post- remission treatment on long-term survival in acute promyelocytic leukemia APLpatients.
目的比较急性早幼粒细胞白血病 APL缓解后采用不同治疗方案对长期生存的影响。 cnki
Objective To investigate the immunophenoytpe of acute promyelocytic leukemia APL and its clinical significance.
目的分析急性早幼粒细胞白血病 APL免疫表型特点及其临床意义。 cnki
Objective To discuss the clinic features and prevention means of acute promyelocytic leukemia APL accompanying central nervous systematic CNS infiltration.
目的探讨急性早幼粒细胞白血病 APL合并中枢神经系统 CNS浸润的临床特征和防治措施。 cnki
Objective To explore nursing of acute promyelocytic leukemia APL combined with DIC.
目的探讨急性早幼粒细胞白血病 APL合并 DIC的护理体会。9med
Objective To further understand the possible mechanism of realgar in the treatment of acute promyelocytic leukemia APL.
目的了解雄黄治疗急性早幼粒细胞白血病 APL的机制。 cnki
Objective To investigate the effect of millimeter wave radiation on proliferation and apoptosis of acute promyelocytic leukemia cell line NB 4 cells.
目的探讨毫米波对人急性早幼粒白血病细胞增殖和凋亡的影响。 cnki
Objective To study the morphologic and cytogenetic change in acute promyelocytic leukemia APL patients during the tetra arsenic tetra sulfide TATS treatment and the mechanism of TATS.
目的观察四硫化四砷 TATS治疗初治和复发急性早幼粒细胞白血病 APL过程中细胞形态学及细胞遗传学变化，探讨其作用机制。 cnki
Objective: To acquire a deep understanding of the possible mechanisms of realgar in the treatment of acute promyelocytic leukemia APL.
目的：深入了解雄黄治疗急性早幼粒细胞白血病 APL的机理。 cnki
Objective: To study the possible mechanism of red orpiment, which is main component of composite indigo naturalis tablets, in the treatment of acute promyelocytic leukemia APL.
目的：研究复方青黛片的主要成分雄黄治疗急性早幼粒细胞白血病 APL的机制。 cnki
Objective:In order to increase our understanding of Sweet's syndrome during treatment of acute promyelocytic leukemia APL with all-trans retinoic acid ATRA.
目的：提高对全反式维甲酸 ATRA治疗急性早幼粒细胞性白血病 APL少见副作用的认识。 cnki
Objective:To explore the effects of MICM detection on diagnosis and treatment of acute promyelocytic leukemia APL.
目的：探讨 MICM检测对急性早幼粒细胞白血病 APL诊断和治疗的影响。 cnki
Objective:To explore an effective remedy for patients with acute promyelocytic leukemia APL after complete remission.
目的：探索一种有效的急性早幼粒细胞白血病 APL缓解后的治疗方案。 dictall
Objective:To illustrate mechanisms of arsenic trioxideAs2O3 in the treatment of acute promyelocytic leukemia APL.
目的：阐明氧化砷治疗急性早幼粒细胞白血病 APL的机制。 cnki
Objective:To study the clinical and molecular efficiency in patients with Acute Promyelocytic Leukemia APL by combined All-trans Retinoic Acid and indarubicin? cytarabine AIDA therapy.
目的：观察全反式维甲酸加去甲氧柔红霉素加阿糖胞苷 AIDA方案治疗急性早幼粒细胞白血病 APL患者的分子生物学疗效。 iciba
Objective:To study the early death reason in patients with acute promyelocytic leukemia APL.
目的：探讨急性早幼粒细胞白血病 APL患者早期死亡原因。 cnki
Part of the acute promyelocytic leukemia cells appeared indigo granules and apoptosis body in plasma through NBT test.
NBT还原实验发现部分早幼粒白血病细胞胞奖内出现紫蓝色颗粒，并见到核碎解成染色质小体凋亡小体。 cnki
Telomerase activity of promyelocytic cells in acute leukemia M3 was inhibited to an undetectable level during differentiation therapy.
诱导分化治疗可使急性白血病 M 3早幼粒细胞端粒酶活性水平降至正常。 cnki
The effects of mouse reticulocyte cytoplasmic factor on differentiation pathway of human promyelocytic leukemia cells were discussed.
本文并讨论了网织红细胞胞质因子对人早幼粒白血病细胞分化途径的影响。 cnki |